Cumulative data in Fig. 3A show that CD3+CD4+ cells from 18 of 40 SLE (45%) (and from three of five CLE patients), proliferated in response to LL37, whereas responses to HBD3 or HNP1–3 were not significant (Fig. 3A). The gene discussed is CD4; the disease is systemic lupus erythematosus.